NM_016156.6:c.130G>A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_016156.6(MTMR2):c.130G>A(p.Val44Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000494 in 1,613,542 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_016156.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00279 AC: 424AN: 152080Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000732 AC: 184AN: 251226Hom.: 0 AF XY: 0.000508 AC XY: 69AN XY: 135782
GnomAD4 exome AF: 0.000255 AC: 373AN: 1461344Hom.: 2 Cov.: 30 AF XY: 0.000231 AC XY: 168AN XY: 726968
GnomAD4 genome AF: 0.00279 AC: 424AN: 152198Hom.: 0 Cov.: 32 AF XY: 0.00265 AC XY: 197AN XY: 74412
ClinVar
Submissions by phenotype
not provided Benign:2
- -
- -
MTMR2-related disorder Benign:1
This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Charcot-Marie-Tooth disease type 4 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at